Related Experiment Videos
Penicillin binding protein 2 is dispensable in Escherichia coli when ppGpp synthesis is induced
Abstract:
Mecillinam, a beta-lactam antibiotic which specifically inactivates penicillin binding protein 2 (PBP2) in Escherichia coli, prevents lateral cell wall elongation, inducing spherical morphology and cell death. Two mecillinam resistant mutants, lov-1 and lovB, both able to dispense entirely with PBP2, are shown here to be affected in the aminoacyl-tRNA synthetase genes argS and alaS, respectively. Although the argS and alaS mutants grow slowly, we show that there is no correlation between mecillinam resistance and either growth rate or translation speed. A role of the ribosomes in mecillinam sensitivity, suggested by our earlier report that the lov-1 mutation is suppressed by certain rpsL(StrR) alleles affecting ribosomal protein S12, is supported by the present observation that a pseudo-streptomycin dependent mutant is mecillinam resistant in the presence of streptomycin. The argS and alaS mutants have high pools of the nucleotide ppGpp (effector of the stringent response) and the mecillinam resistance of both mutations is suppressed by a relA mutation, inactivating the ribosome-associated ppGpp synthetase and preventing ppGpp synthesis in response to aminoacyl-tRNA starvation. Furthermore, a ptacrelA' multicopy plasmid makes a wild type strain mecillinam resistant. The effect of ppGpp is probably mediated by RNA polymerase, since sublethal doses of the polymerase inhibitor rifampicin suppress mecillinam resistance in argS, alaS and ptacrelA'-bearing strains. We conclude that ppGpp regulates the transcription of a gene whose product is involved in mecillinam sensitivity, possibly as part of a chain of interacting elements which coordinate ribosomal activity with that of the PBPs.
Insights
Mecillinam resistance in E. coli is linked to aminoacyl-tRNA synthetase genes, not growth rate. The stringent response nucleotide ppGpp regulates transcription, influencing mecillinam sensitivity and coordinating ribosomal activity with penicillin-binding proteins.
Area of Science:
- Microbiology
- Molecular Biology
- Genetics
Background:
- Mecillinam is a beta-lactam antibiotic targeting penicillin-binding protein 2 (PBP2) in Escherichia coli, crucial for cell wall synthesis.
- Resistance to mecillinam can arise from mutations affecting PBP2 function or related cellular processes.
Purpose of the Study:
- To investigate the genetic basis of mecillinam resistance in Escherichia coli.
- To elucidate the role of ribosomal function and stringent response in mecillinam sensitivity.
Main Methods:
- Isolation and characterization of mecillinam-resistant mutants (lov-1, lovB).
- Genetic analysis of mutations in aminoacyl-tRNA synthetase genes (argS, alaS).
- Assessment of ppGpp levels, stringent response, and ribosomal protein S12 interactions.
Main Results:
- Mecillinam resistance mutations were identified in argS and alaS genes, encoding aminoacyl-tRNA synthetases.
- Mecillinam resistance was not correlated with growth rate or translation speed.
- High ppGpp levels were associated with resistance, and resistance was suppressed by relA mutations and rifampicin.
Conclusions:
- The stringent response nucleotide ppGpp plays a regulatory role in mecillinam sensitivity.
- ppGpp likely affects transcription of a gene involved in mecillinam sensitivity, coordinating ribosome and PBP activity.
- This suggests a complex interplay between translation, stringent response, and cell wall synthesis regulation.